Target Price | $34.68 |
Price | $34.10 |
Potential | 1.70% |
Number of Estimates | 26 |
26 Analysts have issued a price target CSX 2026 . The average CSX target price is $34.68. This is 1.70% higher than the current stock price. The highest price target is $39.90 17.01% , the lowest is $27.27 20.03% . | |
A rating was issued by 31 analysts: 18 Analysts recommend CSX to buy, 13 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CSX stock has an average upside potential 2026 of 1.70% . Most analysts recommend the CSX stock at Purchase. |
27 Analysts have issued a sales forecast CSX 2025 . The average CSX sales estimate is $14.4b . This is 0.85% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $15.2b 6.56% , the lowest is $13.7b 3.88% .
This results in the following potential growth metrics:
2024 | $14.5b | 0.80% |
---|---|---|
2025 | $14.4b | 0.94% |
2026 | $15.1b | 4.62% |
2027 | $15.6b | 3.86% |
2028 | $16.4b | 4.97% |
2029 | $17.2b | 4.78% |
2030 | $17.4b | 1.34% |
24 Analysts have issued an CSX EBITDA forecast 2025. The average CSX EBITDA estimate is $6.6b . This is 0.06% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.2b 8.09% , the lowest is $6.1b 7.20% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $7.0b | 1.02% |
---|---|---|
2025 | $6.6b | 5.34% |
2026 | $7.2b | 8.77% |
2027 | $7.7b | 6.58% |
2028 | $8.2b | 7.36% |
2029 | $8.6b | 4.50% |
2024 | 48.14% | 0.22% |
---|---|---|
2025 | 46.00% | 4.45% |
2026 | 47.83% | 3.98% |
2027 | 49.08% | 2.61% |
2028 | 50.20% | 2.28% |
2029 | 50.06% | 0.28% |
29 CSX Analysts have issued a net profit forecast 2025. The average CSX net profit estimate is $3.1b . This is 3.10% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.5b 6.67% , the lowest is $2.9b 11.82% .
This results in the following potential growth metrics and future Net Margins:
2024 | $3.5b | 5.40% |
---|---|---|
2025 | $3.1b | 9.64% |
2026 | $3.7b | 16.67% |
2027 | $4.0b | 10.24% |
2028 | $4.5b | 11.19% |
2029 | $5.0b | 11.00% |
2030 | $5.4b | 8.26% |
2024 | 23.87% | 4.64% |
---|---|---|
2025 | 21.77% | 8.78% |
2026 | 24.28% | 11.53% |
2027 | 25.77% | 6.14% |
2028 | 27.30% | 5.94% |
2029 | 28.92% | 5.93% |
2030 | 30.89% | 6.81% |
29 Analysts have issued a CSX forecast for earnings per share. The average CSX EPS is $1.67 . This is 2.34% lower than earnings per share in the financial year 2024. The highest EPS forecast is $1.84 7.60% , the lowest is $1.52 11.11% .
This results in the following potential growth metrics and future valuations:
2024 | $1.79 | 1.65% |
---|---|---|
2025 | $1.67 | 6.70% |
2026 | $1.95 | 16.77% |
2027 | $2.15 | 10.26% |
2028 | $2.39 | 11.16% |
2029 | $2.65 | 10.88% |
2030 | $2.87 | 8.30% |
Current | 19.94 | 9.59% |
---|---|---|
2025 | 20.43 | 2.45% |
2026 | 17.51 | 14.29% |
2027 | 15.88 | 9.31% |
2028 | 14.29 | 10.01% |
2029 | 12.87 | 9.94% |
2030 | 11.89 | 7.61% |
Based on analysts' sales estimates for 2025, the CSX stock is valued at an EV/Sales of 5.70 and an P/S ratio of 4.45 .
This results in the following potential growth metrics and future valuations:
Current | 5.74 | 2.68% |
---|---|---|
2025 | 5.70 | 0.77% |
2026 | 5.44 | 4.41% |
2027 | 5.24 | 3.71% |
2028 | 4.99 | 4.73% |
2029 | 4.77 | 4.57% |
2030 | 4.70 | 1.32% |
Current | 4.49 | 1.67% |
---|---|---|
2025 | 4.45 | 0.84% |
2026 | 4.25 | 4.41% |
2027 | 4.09 | 3.71% |
2028 | 3.90 | 4.74% |
2029 | 3.72 | 4.57% |
2030 | 3.67 | 1.32% |
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Overweight
➜
Overweight
|
Unchanged | Jul 10 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Jul 09 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jul 08 2025 |
Bernstein |
Market Perform
➜
Market Perform
|
Unchanged | Jul 08 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 07 2025 |
Baird |
➜
Outperform
|
Unchanged | Jul 01 2025 |
Susquehanna |
Positive
➜
Neutral
|
Downgrade | Jun 24 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jul 10 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Jul 09 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jul 08 2025 |
Unchanged
Bernstein:
Market Perform
➜
Market Perform
|
Jul 08 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Jul 07 2025 |
Unchanged
Baird:
➜
Outperform
|
Jul 01 2025 |
Downgrade
Susquehanna:
Positive
➜
Neutral
|
Jun 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.